Effect of temozolamide on seizure frequency in patients with oligodendrogliomas

Trial Profile

Effect of temozolamide on seizure frequency in patients with oligodendrogliomas

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 May 2017

At a glance

  • Drugs Temozolomide (Primary)
  • Indications Oligodendroglioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 May 2017 New trial record
    • 28 Apr 2017 Results presented at the 69th Annual Meeting of the American Academy of Neurology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top